paliperidone palmitate
Generic: PALIPERIDONE PALMITATE·Brand: ERZOFRI, INVEGA HAFYERA, INVEGA SUSTENNA, INVEGA TRINZA
paliperidone palmitate: 1 clinical trial tracked.
paliperidone palmitate evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about paliperidone palmitate, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
A Prospective, Matched-Control, Randomized, Open-Label, Flexible-Dose, Study in Subjects With Recent-Onset Schizophrenia or Schizophreniform Disorder to Compare Disease Progression and Disease Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics
Primary endpoint: Part-2 (Disease Progression): Time to First Treatment Failure
InterventionalRandomizedopen337 enrolledStarted 2015-07Completion 2019-1138 sites · Brazil, Mexico, United StatesJanssen Scientific Affairs, LLC